Business Sun Pharmaceuticals Rating ‘Buy’; Lower costs boosted Q3 performance News Desk February 8, 2021 Improving patient flows on the broader market recovery and improved execution of marketing and promotional efforts led to a healthy pick-up in specialty sales during Q3. Sun’s strong Q3 beat …